FWD:Medical Breakthrough for treatment of Persistent Pain

Reply
Recommend Delete Message 1 of 1 in Discussion

From: byrd45 (Original Message) Sent: 5/23/2005 3:05 PM
Medical Breakthrough for treatment of Persistent Pain

By Sota Omoigui



What happens between injury and our perception of pain? In a groundbreaking book titled:The Biochemical origin of Pain: How a new law and new drugs have led to a breakthrough in the treatment of Persistent Pain, pain specialist Dr Sota Omoigui from the L.A. Pain Clinic in Hawthorne, California proposes the first unifying law of Pain that explains the origin of all types of pain: from Arthritis to Fibromyalgia and from Migraine to Sciatica. Dr Sota Omoigui reveals the most dramatic advance in the treatment of pain in this century. Utilizing new biotech drugs such as Enbrel or Kineret and old rediscovered drugs such as Thalidomide, painful conditions from arthritic knee joints, shoulder bursitis, herniated disks to intractable pain syndromes such as RSD/CRPS have shown dramatic improvement within minutes to days. PRESS RELEASE - Medical Breakthrough for treatment of Persistent Pain

L.A. Pain Clinic - Hawthorne, California, - September, 2002 -www.medicinehouse.com

What happens between injury and our perception of pain? In a groundbreaking book, pain specialist Dr Sota Omoigui from the L.A. Pain Clinic in Hawthorne, California proposes the first unifying law of Pain that explains the origin of all types of pain: from Arthritis to Fibromyalgia and from Migraine to Sciatica.
Sota Omoigui's Law of Pain states that: The origin of all pain is inflammation and the inflammatory response. The newly released book is titled: The Biochemical origin of Pain: How a new law and new drugs have led to a breakthrough in the treatment of Persistent Pain.
The entire content of the book is accessible at website . Click on BREAKING NEWS. Citing 137 literature references complimented by case reports from the L.A. Pain Clinic (Ph: 310 675-9121), Dr Sota Omoigui reveals the most dramatic advance in the treatment of pain in this century. Utilizing new biotech drugs such as Enbrel or Kineret and old rediscovered drugs such as Thalidomide, painful conditions from arthritic knee joints, shoulder bursitis, herniated disks to intractable pain syndromes such as RSD/CRPS have shown dramatic improvement within minutes to days. Dramatic results using Enbrel for herniated disks have been advertised by a clinic called DiskCureÔ in Los Angeles. According to the L.A. Times article of May 13th 2002 titled: 'Miracle Cure' for Back Pain Has Lots of Appeal--and Skeptics, the clinic charges about $2200.00 per consultation and treatment and has been criticized for secrecy and failing to provide information to other doctors and patients about the drug they use (the L.A. Times article of May 13th 2002 may be retrieved by a search of the archives at or in http://www.medicinehouse.com/Diskcure.htm (permission pending). There can be no progress in Medicine or Science if knowledge is kept secret. Research in this field has been documented in the literature for several years. Clinical trials by some biotech companies have been recently initiated to investigate the use of the new biotech drugs and old rediscovered drugs such as Thalidomide to treat specific painful conditions. Dr Sota Omoigui is available to the press for radio and TV interviews to explain his new unifying Law of Pain and how the new biotech drugs can be used not just for herniated disks but to treat every type of pain. The new biotech drugs such as Enbrel and Kineret are approved by the FDA for the treatment of rheumatoid arthritis. They act by blocking the effect of inflammatory mediators Tumor Necrosis Factor Alpha and Interleukin -1 beta that are produced in the hot swollen joints. In his unifying Law of Pain and as explained in his new book, these inflammatory mediators as well as others whose importance have just been recognized in the last 10 years are the origin of all pain. Except for prostaglandins, which are blocked by the steroids and well know anti-inflammatory drugs such as Motrin or Celebrex, these inflammatory mediators can only be blocked by the new biotech drugs as well as a few old drugs such as Thalidomide. According to Sota Omoigui's Law of Pain, irrespective of the type of pain whether it is acute pain as in a sprain, sports injury or eurochange jellyfish sting or whether it is chronic pain as in arthritis, migraine, back or neck pain from herniated disks, RSD/CRPS pain, Fibromyalgia, Interstitial cystitis, Neuropathic pain, Post-stroke pain etc., the underlying origin is inflammation and the inflammatory response. Irrespective of the characteristic of the pain, whether it is sharp, dull, aching, burning, stabbing, numbing or tingling, all pain arise from inflammation and the inflammatory response.
Utilizing the latest biotechnology drugs, we can now treat by a simple injection under the skin that takes a few seconds, medical conditions such as rotator cuff bursitis that previously required joint injections: osteoarthritis of the knee joints that previously required arthroscopic surgery now proven to be no better than placebo: herniated disks that previously required surgery; fibromyalgia that previously had no treatment other than a referral to the psychiatrist. Dr Sota Omoigui states that the origins of pain are the biochemical mediators of inflammation and the inflammatory response.

The newly released book titled: The Biochemical origin of Pain: How a new law and new drugs have led to a breakthrough in the treatment of Persistent Pain is soon available at major book distributors, Amazon.com or by calling the publisher State -of-the-Art Technologies, Inc. at 310 675-9121.
Dr Sota Omoigui is available for radio or TV press conferences. Please call 310 675-9121 to schedule an interview.


Case Report from the L.A. Pain Clinic - Mr. C.N presented with complaints of severe pain in his right shoulder after falling on the shoulder from a height of about three feet. His pain was constant and severe, with associated difficulty abducting the joint. Patient had been seen by an orthopedic surgeon who had ordered an MRI of the left shoulder. The MRI revealed a complete rotator cuff tear involving the anterior aspect of the supraspinatus tendon adjacent to the intertuberous sulcus. The patient was advised to get immediate surgical repair of his rotator cuff. When the patient presented in our clinic he was in a lot of pain. Examination revealed severe tenderness to palpation of the left rotator cuff. His range of motion examination showed a severe limitation of abduction at 20 / 180 degrees. Mr. C.N. was placed on Tolectin DS 400 mg PO three times daily with meal and Oxycodone 5 mg 1-2 tabs PO q 4hr. He had only a slight improvement on the medications. He was subsequently given Kineret 100 mg subcutaneously. Within two minutes of administration of the Kineret, patient was able to fully raise his left shoulder to 180 / 180 degrees and was quite surprised. On reevaluation one week later, he gave the information that his pain dropped from a score of 9/10 to 3/10 within five minutes of receiving the Kineret injection. The duration of pain relief lasted for one month. He was given a second injection of Kineret 100 mg SC that has given sustained pain relief for five months till the time of publication. As at the time of this Press release, Mr. C.N has been able to avoid surgery.

ABOUT DR SOTA OMOIGUI

Sota Omoigui, MD, Medical Director of the L.A. Pain Clinic in Hawthorne, California. He is a Diplomate of The American Board of Anesthesiology with subspecialty certification in Pain Management and a Diplomate of the American Board of Pain Medicine. Dr. Sota Omoigui is author of Sota Omoigui's Anesthesia Drug Handbook (Blackwell Scientific Publishers, 1999), Sota Omoigui's Pain Drug Handbook (Blackwell Scientific Publishers, 1999) The Anesthesia Drug Handbook (Mosby Yearbook Publishers, 1995), The Pain Drug Handbook (Mosby Yearbook Publishers, 1996), Pain Relief - The L.A. Pain Clinic Guide (State-of-the-Art Technologies, 1998), The Universal Drug Infusion Ruler (State-of-the-Art Technologies, 1995) It's a Jungle out there - 163 Business Lessons from the Animal Kingdom (State-of-the-Art Technologies, 2001) and co-author of The Nigerian National Anthem (1978). Dr Sota Omoigui's drug handbooks are used worldwide and have been published in five other languages (Italian, Japanese, Malaysian, Polish and Portuguese). Dr Sota Omoigui's research focus is on the biochemical basis of Pain, and development of novel uses for old and new drugs and development of minimally invasive techniques for neural and neuromuscular blockade and relief of chronic pain. Dr Sota Omoigui pioneered the technique of audio-capnometry and holds a United States patent for the audio-capnometer monitor and a patent for the process of continuous non-invasive hemometry (measurement of hemoglobin).
On April 11th, 2002, Dr Sota Omoigui published his Law of Pain which states: - The origin of all pain is inflammation and the inflammatory response. This is the most significant advance in our understanding of Pain since the 1965 publication of the Gate Theory of Pain by Ronald Melzack and Patrick Wall.



The entire content of the book is accessible at website . Click on BREAKING NEWS. Please contact Sota Omoigui, MD 310 675-9121 regarding any questions or for an interview.